Skip to main content

CORRECTION article

Front. Mol. Biosci., 31 October 2023
Sec. Molecular Diagnostics and Therapeutics
Volume 10 - 2023 | https://doi.org/10.3389/fmolb.2023.1325104

Corrigendum: VIDIIA Hunter: a low-cost, smartphone connected, artificial intelligence-assisted COVID-19 rapid diagnostic platform approved for medical use in the UK

This article is a correction to:

  1. VIDIIA Hunter: a low-cost, smartphone connected, artificial intelligence-assisted COVID-19 rapid diagnostic platform approved for medical use in the UK

    1. Read original article
Aurore C. Poirier Aurore C. Poirier1*Ruben D. Riao MorenoRuben D. Riaño Moreno2Leona TakaindisaLeona Takaindisa1Jessie CarpenterJessie Carpenter2Jai W. MehatJai W. Mehat3Abi Haddon&#x;Abi Haddon4†Mohammed A. RohaimMohammed A. Rohaim5Craig WilliamsCraig Williams6Peter BurkhartPeter Burkhart6Chris ConlonChris Conlon7Matthew WilsonMatthew Wilson7Matthew McClumphaMatthew McClumpha7Anna StedmanAnna Stedman1Guido CordoniGuido Cordoni1Manoharanehru BranavanManoharanehru Branavan8Mukunthan TharmakulasingamMukunthan Tharmakulasingam9Nouman S. ChaudhryNouman S. Chaudhry9Nicolas Locker&#x;Nicolas Locker3†Anil Fernando&#x;Anil Fernando9†Wamadeva BalachandranWamadeva Balachandran8Mark BullenMark Bullen7Nadine CollinsNadine Collins4David RimerDavid Rimer2Daniel L. HortonDaniel L. Horton1Muhammad MunirMuhammad Munir5Roberto M. La Ragione, Roberto M. La Ragione1,3*
  • 1Department of Comparative Biomedical Sciences, School of Veterinary Medicine, University of Surrey, Guildford, United Kingdom
  • 2VIDIIA Ltd., Surrey Technology Centre, Guildford, United Kingdom
  • 3Department of Microbial Sciences, School of Biosciences, University of Surrey, Guildford, United Kingdom
  • 4Berkshire and Surrey Pathology Services, Molecular Diagnostics, Royal Surrey County Hospital, Guildford, United Kingdom
  • 5Division of Biomedical and Life Sciences, Faculty of Health and Medicine, The Lancaster University, Lancaster, United Kingdom
  • 6The Royal Lancaster Infirmary, University Hospitals of Morecambe Bay NHS Foundation Trust, Kendal, United Kingdom
  • 7GB Electronics (UK) Ltd., Worthing, United Kingdom
  • 8College of Engineering, Design and Physical Sciences, Brunel University London, Uxbridge, United Kingdom
  • 9Centre for Vision, Speech and Signal Processing, University of Surrey, Guildford, United Kingdom

A Corrigendum on
VIDIIA Hunter: a low-cost, smartphone connected, artificial intelligence-assisted COVID-19 rapid diagnostic platform approved for medical use in the UK

by Poirier AC, Riaño Moreno RD, Takaindisa L, Carpenter J, Mehat JW, Haddon A, Rohaim MA, Williams C, Burkhart P, Conlon C, Wilson M, McClumpha M, Stedman A, Cordoni G, Branavan M, Tharmakulasingam M, Chaudhry NS, Locker N, Fernando A, Balachandran W, Bullen M, Collins N, Rimer D, Horton DL, Munir M and La Ragione RM (2023). Front. Mol. Biosci. 10:1144001. doi: 10.3389/fmolb.2023.1144001

In the published article, there was an error in the Article title. Instead of “VIDIIA Hunter diagnostic platform: a low-cost, smartphone connected, artificial intelligence-assisted COVID-19 rapid diagnostics approved for medical use in the UK,” it should be “VIDIIA Hunter: a low-cost, smartphone connected, artificial intelligence-assisted COVID-19 rapid diagnostic platform approved for medical use in the UK”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: rapid diagnostics, LAMP (loop mediated isothermal amplification), COVID-19, artificial intelligence, infectious diseases

Citation: Poirier AC, Riaño Moreno RD, Takaindisa L, Carpenter J, Mehat JW, Haddon A, Rohaim MA, Williams C, Burkhart P, Conlon C, Wilson M, McClumpha M, Stedman A, Cordoni G, Branavan M, Tharmakulasingam M, Chaudhry NS, Locker N, Fernando A, Balachandran W, Bullen M, Collins N, Rimer D, Horton DL, Munir M and La Ragione RM (2023) Corrigendum: VIDIIA Hunter: a low-cost, smartphone connected, artificial intelligence-assisted COVID-19 rapid diagnostic platform approved for medical use in the UK. Front. Mol. Biosci. 10:1325104. doi: 10.3389/fmolb.2023.1325104

Received: 20 October 2023; Accepted: 24 October 2023;
Published: 31 October 2023.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2023 Poirier, Riaño Moreno, Takaindisa, Carpenter, Mehat, Haddon, Rohaim, Williams, Burkhart, Conlon, Wilson, McClumpha, Stedman, Cordoni, Branavan, Tharmakulasingam, Chaudhry, Locker, Fernando, Balachandran, Bullen, Collins, Rimer, Horton, Munir and La Ragione. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Aurore C. Poirier, a.poirier@surrey.ac.uk; Roberto M. La Ragione, r.laragione@surrey.ac.uk

†Present addresses: Abi Haddon, Exeter Genomics Laboratory, Royal Devon and Exeter NHS Foundation Trust, Exeter, United Kingdom
Nicolas Locker, The Pirbright Institute, Pirbright, United Kingdom
Anil Fernando, Department of Computer and Information Sciences, University of Strathclyde, Glasgow, United Kingdom

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.